Sorrento Therapeutics gets FDA approval for COVID-19 drug trial

Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Anjalee Khemlani speak with Sorrento Therapeutics CEO & Founder Dr. Henry Ji about the company’s FDA clearance for a COVID-19 drug trial, to be used on patients with milder symptoms.